Učitavanje...
Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator
Three patients affected by Behçet’s disease (BD) with severe uveitis and neurological involvement in stable clinical remission and who rapidly relapsed after switching from reference infliximab (re-IFX) to biosimilar infliximab (bio-IFX) are reported. In order to observe the rules of local health au...
Spremljeno u:
| Izdano u: | Eur J Rheumatol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medical Research and Education Association
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741345/ https://ncbi.nlm.nih.gov/pubmed/29308287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16112 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|